Analystreport

Bio-Path Holdings, Inc. (NASDAQ: BPTH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.

Bio-Path Holdings, Inc.  (BPTH) 
Last bio-path holdings, inc. earnings: 11/14 04:20 pm Check Earnings Report
US:NASDAQ Investor Relations: biopathholdings.com